Bandingkan Harga & Kinerja Petrindo Jaya Kreasi Tbk. (CUAN) vs UBC Medical Indonesia Tbk. (LABS)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Petrindo Jaya Kreasi Tbk. dan UBC Medical Indonesia Tbk.: Petrindo Jaya Kreasi Tbk. diperdagangkan di Rp840 (kapitalisasi pasar 97,8 T, volume 24 jam 1,55 M), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp165 (kapitalisasi pasar 635,95 M, volume 24 jam 843 rb). Perbedaan utamanya: Petrindo Jaya Kreasi Tbk. jauh lebih besar — sekitar 153,8× kapitalisasi pasar UBC Medical Indonesia Tbk., dan Petrindo Jaya Kreasi Tbk. lebih aktif diperdagangkan (1,55 M vs 843 rb). Mana yang lebih baik tergantung tujuan investasimu.
| CUAN | LABS | |
|---|---|---|
Kapitalisasi Pasar | 97,8 T | 635,95 M |
Volume | 1,55 M | 843 rb |
Lot | 15,46 jt | 8,43 rb |
Perputaran | 1,3 T | 137,6 jt |
Harga Rata-rata | 841,48 | 163,22 |
Nilai Transaksi | 1,3 T | 137,6 jt |
Harga Ekuilibrium Indikatif | 840 | 165 |
Volume Ekuilibrium Indikatif | 115,93 rb | 246 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Petrindo Jaya Kreasi Tbk.
PT Petrindo Jaya Kreasi Tbk (the Entity) was established based on Deed No. 12 dated 04 Aug 2008 by Notary Benny Kristianto, S.H, Notary in Jakarta. The Company started its commercial operations on December, 2012
Selengkapnya di halaman CUAN →Tentang UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →
